SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Brown JJ, Nanayakkara CS. Clin. Toxicol. (Phila) 2005; 43(4): 297-299.

Affiliation

Department of Endocrinology and Diabetes and Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia. justin.brown@mcri.edu.au

Copyright

(Copyright © 2005, Informa - Taylor and Francis Group)

DOI

unavailable

PMID

16035208

Abstract

INTRODUCTION: The following case report highlights the dangers of acetone-free nail polish remover products which are widely regarded as safe. CASE REPORT: A 15-month-old presented with coma and cardiorespiratory collapse after sucking on Boots Conditioning Nail Polish Remover Pads, which was complicated by features of upper airway obstruction, bilateral pneumothoraces, and pneumomediastinum. The child required intubation and ventilation for 5 days along with full supportive management before making a complete recovery. The clinical features in this case resemble those of poisoning due to gamma butyrolactone, the principal component of this nail polish remover. Gamma butyrolactone is rapidly metabolized to gamma hydroxybutyrate on ingestion, a compound whose toxicity is well recognized. Package labeling gave no indication of the potential toxicity of its components. CONCLUSION: We wish to draw attention to the potential toxicity of gamma butyrolactone containing nail polish removers and the need for appropriate labeling of product packaging. Since alternative products are available, these products should be removed from the market.

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print